SU2C Lung Cancer Early Detection Challenge Grants
SU2C Lung Cancer Early Detection Challenge Grants support researchers evaluating alternatives to DNA-based and blood-based assays for early lung cancer detection to improve outcomes in smokers.
Browse similar grants
Funder: Stand Up To Cancer
Due Dates: Open application (deadline not specified)
Funding Amounts: Award amount and duration not specified
Summary: Supports evaluation of alternatives to DNA-based and blood-based assays for early lung cancer detection before treatment, aiming to improve outcomes in smokers.
Key Information: Applications should propose detection modalities alternative to DNA-based and blood-based assays.
Description
The SU2C Lung Cancer Early Detection Challenge Grants, run by Stand Up To Cancer, support evaluation of different platforms for detecting lung cancer before treatment to improve outcomes in smokers. The challenge focuses on alternatives to DNA-based and blood-based assays. Examples include RNA in saliva, protein analytes in urine, and volatile organic compounds (VOCs) from breath.
The opportunity sits within SU2C’s broader support for cancer research addressing critical problems in patient care and delivering near-term patient benefits. SU2C encourages novel, collaborative, high-impact proposals and favors goal-oriented projects with defined milestones and deliverables. Its selection principles emphasize collaboration, information sharing, and health equity in both project goals and team makeup, alongside regular progress reviews.
